Stockreport

Will Extended Cash Runway And Dual FDA Filings Shift Praxis Precision Medicines' (PRAX) Narrative Toward Commercialization? [Yahoo! Finance]

Praxis Precision Medicines, Inc.  (PRAX) 
PDF At the same time, the company has filed FDA new drug applications for ulixacaltamide and relutrigine, both with Breakthrough Therapy Designation, signaling a possible s [Read more]